1. Responsiveness of the p-adrenoceptor adenylate cyclase system was measured in lymphocytes from healthy young and old subjects by incubating the cells with isoprenaline in the presence of a phosphodiesterase inhibitor and by measuring production of adenosine 3' :5' -cyclic monophosphate (cyclic AMP) with a competitive binding assay.
Introduction
There is conflicting evidence on whether the responsiveness of the p-adrenoceptor adenylate cyclase system is altered in the elderly.
A study in man in vivo showed that the physiological response to both isoprenaline and propranolol was reduced in healthy elderly subjects (Vestal, Wood & Shand, 1979) . A fan in p-adrenoceptor numbers with aging has also been reported (Schocken & Roth, 1977) .
Some work in vitro has shown a decreased
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response to p-agonists with aging (Berger, Preiss, Hesse-Wortmann & Gries, 1971; Ericsson, 1974; Cooper & Gregerman, 1976; Chung, Dillon, Kelly & O'Malley, 1979) whereas other studies have demonstrated the converse (Kranz & Wollenberger, 1976; Kalish, Katz, Pineyro & Gregerman, 1977) .
In the present study we have examined the stimulation of adenosine 3':5'-cyclic monophosphate (cyclic AMP) formation in lymphocytes from healthy old and young human subjects as a measure of the primary receptor response to p-agonists.
Materials and methods

Subjects
Ten old and 10 young subjects were studied (for details see Table 1 ). An were healthy volunteer subjects; none had any history of atopy, smoked or took regular medication.
Blood samples
Each subject was tested on two separate occasions. All subjects were free from any medication for 3 days before blood sampling and abstained from alcohol and caffeine for 12 h. Between 09.00 and 10.00 hours, 30 or 40 ml of venous blood was drawn into ethylenediaminetetra-acetate (EDTA).
Preparation and incubation oflymphocytes
Lymphocytes were prepared by a modification of the technique of Boyum (1968) . Portions of blood were layered over an equal 0143-5221/81/050587-03$01.50/1 © 1981 The Biochemical Society and the Medical Research Society volume of lymphocyte separation medium (Flow Laboratories Ltd, Irvine, Ayrshire, Scotland, U.K.) and centrifuged at 400 g for 30 min. The lymphocyte layer was taken off; the cells were washed in medium 199 containing Hanks salts, Hepes buffer (25 mmol/I) and L-glutamine (IOOmg/l) (Gibco Europe Ltd, Paisley, Scotland, U.K.), and resuspended to a final concentration of 1-3 x 10 6 cells/ml (above 95% of these cells being viable).
The incubation procedure was a modification of the method of Makino, Ikemori, Kashima & Fukuda (I977). Aliquots of cell suspension were preincubated at 37°C for 10 min. Medium 199 (as above) was added containing 3-isobutyll-methylxanthine (to give a final concentration of I mmol/l) and (±)-isoprenaline (Suscardia, Pharmax Ltd, Bexley, Kent, U.K.). After a further 15 min incubation the cells were sedimented by centrifugation, the supernatants discarded and cell pellets frozen in solid carbon dioxide/acetone and thawed in distilled water. Protein was precipitated by boiling and sedimented by centrifugation. The supernatants were stored at -20°C. Cyclic AMP was assayed by a competitive protein-binding method with a commercial kit (cyclic AMP assay kit, The Radiochemical Centre, Amersham, Bucks., U.K.). This assay is highly specific for cyclic AMP; a 200-fold excess of guanidine (3' :5'-cyclic monophosphate (cyclic GMP) is required to give 50% inhibition of binding. Absence of interference by other substances was confirmed by obtaining binding curves in the presence of cell extracts previously treated with phosphodiesterase.
Statistical analysis
The basal and stimulated cyclic AMP levels and the concentrations of isoprenaline required to give half-maximal cyclic AMP production (ED so) in the two groups were compared by Wilcoxon's test for unpaired data.
Results
There were no significant differences between the two age groups in basal cyclic AMP levels, production of cyclic AMP in response to isoprenaline stimulation or in the ED so for isoprenaline (Table 1) .
There was some variation in cyclic AMP levels in a single subject measured on several occasions (mean coefficient of variation 36%) and also among the subjects in each group (mean coefficients of variation of 42 and 37% in the young and old groups respectively). The (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) reproducibility of measurements on replicate samples was very high.
Discussion
The results of the present study do not agree with those of several earlier studies in man, which have suggested that fJ-adrenoceptor sensitivity is reduced with aging. Vestal et at. (I979) found that the effect of isoprenaline on the resting heart and the ability of a given free concentration of propranolol to antagonize this effect were decreased in older healthy subjects. Such results may indicate reduced fJ-adrenoceptor sensitivity with aging, but considerable cardiovascular system adjustment also takes place in such situations in vivo and thus heart rate is only an indirect measure of fJ-adrenergic response. Schocken & Roth (I977) reported a decrease in fJ-adrenoceptor density on human lymphocytes with advancing age, and Chung et at. (1979) found both a reduction in the ED so and maximal response to isoprenaline of cyclic AMP formation in such cells. However, these latter workers compared healthy young subjects with geriatric patients and it is well established that alterations in drug pharmacokinetics and dynamics occur with disease (see Smith & Rawlins, 1973; Crooks & Stevenson, 1979 (Levitzki, 1976 ) the present results suggest that lymphocyte {J-adrenoceptor numbers did not alter with age. Some of the variation within and between subjects may reflect differences in the relative densities of lymphocyte subpopulations. Pochet, Delespesse, Gauset & Collet (1979) showed that {J-adrenoceptors are not equally distributed in the different subpopulations of purified human T and and B lymphocytes. Apparent changes in {J-adrenoceptor sensitivity can also result from altered levels of circulating catecholamines and exogenous {J-agonists (Greenacre & Conolly, 1978; Mackenzie, Popkin, Sheppard, Stillner, Davis & Fenimore, 1980) . Since there is a linear rise in plasma adrenaline and noradrenaline concentrations with aging (Lake, Ziegler, Coleman & Kopin, 1977; Sever, Osikowska, Birch & Tunbridge, 1977) , this would be expected to cause a decreased receptor sensitivity in the elderly although the present studies have not shown this.
In conclusion, we have found no evidence of an age-related change in the responsiveness of the {J-adrenoceptor adenylate cyclase system in healthy human subjects.
